15,022 Shares in Theratechnologies Inc. (NASDAQ:THTX) Purchased by Raymond James Financial Inc.

Raymond James Financial Inc. acquired a new stake in shares of Theratechnologies Inc. (NASDAQ:THTX) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 15,022 shares of the company’s stock, valued at approximately $27,000.

Separately, National Bank of Canada FI increased its position in Theratechnologies by 29.4% during the 3rd quarter. National Bank of Canada FI now owns 186,815 shares of the company’s stock valued at $232,000 after purchasing an additional 42,435 shares during the period.

Theratechnologies Stock Up 45.9 %

Shares of NASDAQ:THTX opened at $1.94 on Monday. The stock has a market cap of $89.20 million, a price-to-earnings ratio of -19.40 and a beta of 1.11. The business has a 50-day moving average price of $1.61 and a 200-day moving average price of $1.51. Theratechnologies Inc. has a 52-week low of $1.08 and a 52-week high of $2.29.

Wall Street Analyst Weigh In

Separately, Research Capitl upgraded shares of Theratechnologies to a “strong-buy” rating in a report on Friday, February 14th.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.